140 related articles for article (PubMed ID: 15972678)
1. DNA augments antigenicity of mycobacterial DNA-binding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice.
Matsumoto S; Matsumoto M; Umemori K; Ozeki Y; Furugen M; Tatsuo T; Hirayama Y; Yamamoto S; Yamada T; Kobayashi K
J Immunol; 2005 Jul; 175(1):441-9. PubMed ID: 15972678
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon.
Troy A; Esparza-Gonzalez SC; Bartek A; Creissen E; Izzo L; Izzo AA
Tuberculosis (Edinb); 2020 Jul; 123():101949. PubMed ID: 32741537
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a booster tuberculosis vaccine containing mycobacterial DNA-binding protein 1 and CpG oligodeoxynucleotide G9.1 using a Guinea pig model that elicits immunity to Bacillus Calmette-Guérin.
Maeyama JI; Iho S; Suzuki F; Hayashi D; Yamamoto T; Yamazaki T; Goto Y; Ozeki Y; Matsumoto S; Yamamoto S
Tuberculosis (Edinb); 2021 May; 128():102067. PubMed ID: 33752142
[TBL] [Abstract][Full Text] [Related]
4. Recombinant mycobacterial DNA-binding protein 1 with post-translational modifications boosts IFN-gamma production from BCG-vaccinated individuals' blood cells in combination with CpG-DNA.
Ozeki Y; Yokoyama A; Nishiyama A; Yoshida Y; Ohara Y; Mashima T; Tomiyama C; Shaban AK; Takeishi A; Osada-Oka M; Yamaguchi T; Tateishi Y; Maeyama JI; Hakamata M; Moro H; Kikuchi T; Hayashi D; Suzuki F; Yamamoto T; Iho S; Katahira M; Yamamoto S; Matsumoto S
Sci Rep; 2024 Apr; 14(1):9141. PubMed ID: 38644371
[TBL] [Abstract][Full Text] [Related]
5. Characterization of murine T-cell epitopes on mycobacterial DNA-binding protein 1 (MDP1) using DNA vaccination.
Suzuki D; Nagata T; Eweda G; Matsumoto S; Matsumoto M; Tsujimura K; Koide Y
Vaccine; 2010 Feb; 28(8):2020-5. PubMed ID: 20188258
[TBL] [Abstract][Full Text] [Related]
6. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
[TBL] [Abstract][Full Text] [Related]
7. Extracellular mycobacterial DNA-binding protein 1 participates in mycobacterium-lung epithelial cell interaction through hyaluronic acid.
Aoki K; Matsumoto S; Hirayama Y; Wada T; Ozeki Y; Niki M; Domenech P; Umemori K; Yamamoto S; Mineda A; Matsumoto M; Kobayashi K
J Biol Chem; 2004 Sep; 279(38):39798-806. PubMed ID: 15234978
[TBL] [Abstract][Full Text] [Related]
8. ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.
Kupz A; Zedler U; Stäber M; Perdomo C; Dorhoi A; Brosch R; Kaufmann SH
J Clin Invest; 2016 Jun; 126(6):2109-22. PubMed ID: 27111234
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
[TBL] [Abstract][Full Text] [Related]
10. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
Kim A; Hur YG; Gu S; Cho SN
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.
Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL
Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075
[TBL] [Abstract][Full Text] [Related]
12. BCG constitutively expressing the adenylyl cyclase encoded by Rv2212 increases its immunogenicity and reduces replication of M. tuberculosis in lungs of BALB/c mice.
Pedroza-Roldán C; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; Aceves-Sánchez MJ; Hernández Pando R; Flores-Valdez MA
Tuberculosis (Edinb); 2018 Dec; 113():19-25. PubMed ID: 30514503
[TBL] [Abstract][Full Text] [Related]
13. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
14. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
15. Enhanced protection against pulmonary mycobacterial challenge by chitosan-formulated polyepitope gene vaccine is associated with increased pulmonary secretory IgA and gamma-interferon(+) T cell responses.
Ai W; Yue Y; Xiong S; Xu W
Microbiol Immunol; 2013 Mar; 57(3):224-35. PubMed ID: 23489083
[TBL] [Abstract][Full Text] [Related]
16. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
Wu M; Li M; Yue Y; Xu W
Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
[TBL] [Abstract][Full Text] [Related]
18. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
[TBL] [Abstract][Full Text] [Related]
20. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
